Oracle, Faces

Oracle Faces Mounting Legal Challenges Over AI Spending and Financial Disclosures

18.02.2026 - 12:43:04 | boerse-global.de

Oracle US68389X1054

Oracle Faces Mounting Legal Challenges Over AI Spending and Financial Disclosures - Foto: über boerse-global.de
Oracle Faces Mounting Legal Challenges Over AI Spending and Financial Disclosures - Foto: über boerse-global.de

The legal pressure on Oracle Corporation continues to intensify. A new securities class action lawsuit has been filed in the United States, bringing the company's substantial expenditures on artificial intelligence data centers and its debt profile back into sharp focus. For shareholders, the allegations are particularly significant as they directly challenge the company's communications regarding its investment strategy, cash flow, and growth projections.

Key Lawsuit Details:
* A class action complaint has been filed in the U.S. District Court for the District of Delaware.
* The class period covers stock purchases made between June 12, 2025, and December 16, 2025.
* The deadline to apply as lead plaintiff is April 6.
* Oracle's share price declined 3.9% on Tuesday, closing at $153.94.

The core accusation in the lawsuit, filed by the law firm Kessler Topaz Meltzer & Check, is that Oracle misled the investment community about its AI infrastructure strategy. The complaint takes issue with management's assertions that significant capital outlays for data center expansion would "quickly" translate into accelerated revenue and profit growth.

Plaintiffs allege the company failed to adequately disclose the associated risks. Specifically, the suit claims Oracle did not properly communicate the financial strain caused by soaring capital expenditures (CapEx) that were not matched by near-term revenue growth. It further contends that risks related to the company's debt levels, credit rating, and free cash flow were understated, and that statements about Oracle's business prospects were materially misleading.

Stock Performance and Broader Context

Oracle's equity came under selling pressure, dropping 3.9% in the latest session. The stock touched an intraday low of $152.88 before settling at $153.94. Trading volume was approximately 19.1 million shares, below the average daily volume of 27.5 million. According to the source material, the stock has exhibited heightened volatility since September 2025, when concerns over AI-related spending first emerged. The current price remains far below its 52-week high of $345.72.

Should investors sell immediately? Or is it worth buying Oracle?

The news backdrop is not uniformly negative. Earlier this month, Oracle secured an $88 million cloud contract with the U.S. Air Force as part of the "Cloud One" program. However, this latest suit adds to a growing list of legal actions; several other law firms have already filed or announced similar class actions concerning Oracle's AI investments and disclosures about its partnership with OpenAI.

Catalysts: Earnings Report and Subsequent Disclosures

The legal claims appear rooted in developments from late 2025. On December 10, Oracle reported financial results for the second quarter of fiscal year 2026. The company posted revenue growth that fell short of analyst expectations, while investment spending exceeded forecasts. Notably, Oracle reported a negative free cash flow exceeding $10 billion.

Subsequent disclosures added fuel to the fire. The company entered into additional data center and cloud capacity lease commitments totaling $248 billion. Furthermore, reports indicated that the completion timeline for certain OpenAI data centers had been pushed back from 2027 to 2028.

Despite these challenges, analyst sentiment has remained generally constructive, albeit with adjustments. Cantor Fitzgerald reduced its price target from $400 to $320, while KeyCorp lowered its target from $350 to $300. Both firms maintained positive ratings on the stock.

All eyes now turn to the procedural deadline of April 6, by which date the court must identify the lead plaintiff who will represent the class of investors in the consolidated case.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from February 18 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 18.

Oracle: Buy or sell? Read more here...

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>

Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.

US68389X1054 | ORACLE | boerse | 68590850 |